Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration

Journal of Neurochemistry

Volumn 85, Issue 6, 2003, Pages 1480-1487

  Castro, Elena ^a   Tordera, Rosa M ^b   Hughes, Zoe A ^b,d   Pei, Qi ^b   Sharp, Trevor ^b,c  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Activity related cytoskeletal protein; Antidepressant; Selective serotonin re uptake inhibitor; WAY 100635

Indexed keywords

ACTIVITY RELATED CYTOSKELETAL PROTEIN; CYTOSKELETON PROTEIN; FENCLONINE; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PROTEIN C FOS; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FRONTAL LOBE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MICRODIALYSIS; MOLECULAR BIOLOGY; NONHUMAN; PARIETAL LOBE; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; BIOLOGICAL MARKERS; CYTOSKELETAL PROTEINS; DRUG SYNERGISM; EXTRACELLULAR SPACE; GENE EXPRESSION; MALE; MICRODIALYSIS; NERVE TISSUE PROTEINS; PAROXETINE; PIPERAZINES; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RNA, MESSENGER; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SYNAPSES;

ANIMALIA; TRIXIS;

EID: 0013249061     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01782.x     Document Type: Article

References (38)

1. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn Schmiedeberg's Arch. Pharmacol. 352, 157-165.
2. Artigas F., Celada P., Laruelle M. and Adell A. (2001) How does pindolol improve antidepressant action? Trends Pharmacol. Sci. 22, 224-228.
3. 1A receptors induced by venlafaxine. Neuropsychopharmacology 23, 294-306.
4. 1A receptor antagonist, WAY 100,635, in the rat. Neuropharmacology 39, 1222-1236.
5. 1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats. Psychopharmacology 134, 55-63.
6. Cirelli C. and Tononi G. (2000) Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J. Neurosci. 20, 9187-9194.
7. 1A receptor antagonist and a SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115, 1064-1070.
8. Gartside S. E., Clifford E. M., Cowen P. J. and Sharp T. (1999) Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br. J. Pharmacol. 127, 145-152.
9. 1B receptors. Neuropsychopharmacology 21, 268-284.
10. 1B receptors with WAY 100,635 and GR 127,935. J. Neurochem. 68, 1159-1163.
11. Gobert A., Dekeyne A. and Millan M. J. (2000) The ability of WAY 100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289 but not BRL15572. Neuropharmacology 39, 1608-1616.
12. Green A. R. and Grahame-Smith D. G. (1976) Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 260, 487-491.
13. 2C receptors. Br J. Pharmacol. 124, 1781-1787.
14. 1A receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission. Synapse 34, 145-153.
15. Hajós M., Richards C. D., Szekely A. D. and Sharp T. (1998) An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87, 95-108.
16. 1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res. 902, 11-17.
17. Hervas I. and Artigas F. (1998) Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role 5-HT autoreceptors. Eur. J. Pharmacol. 358, 9-18.
18. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60, 776-779.
19. Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikstrom H., Arvidsson L.-E., Hacksell U. and Nilson J. L. G. (1982) 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, apotent and selective simpified ergot congener with central 5-HT receptor stimulating activity. J. Neural. Transm. 55, 169-188.
20. Hjorth S., Bengtsson H. J., Kullberg A., Carlzon D., Peilot H. and Auerbach S. B. (2000) Serotonin autoreceptor function and antidepressant drug action. J. Psychopharmacol. 14, 177-185.
21. Invernizzi R., Belli S. and Samanin R. (1992) Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug effect in the frontal cortex. Brain Res. 584, 322-324.
22. 1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36, 467-473.
23. 1C receptors mediate 1-3 (chlorophenyl) piperazine-induced hypophagia. Br. J. Pharmacol. 103, 2016-2020.
24. Knobelman D. A., Hen R. and Lucki I. (2001) Genetic regulation of extracellular serotonin by 5-hydroxytryptamine (1A) and 5-hydroxytryptamine (1B) autoreceptors in different brain regions of the mouse. J. Pharmacol. Exp. Ther. 298, 1083-1091.
25. 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres. Neuroscience 53, 457-463.
26. Li X. M., Perry K. W. and Wong D. T. (1999) Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Chin. J. Physiol. 42, 53-59.
27. McQuade R. and Sharp T. (1997) Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem. 69, 791-796.
28. 1B receptors. Eur. J. Pharmacol. 321, 407-409.
29. Miller M., Urban J. and Dorsa D. (1989) Quantification of mRNA in discrete cell groups of brain by in situ hybridization histochemistry, in Methods in Neuroscience Gene Probes, Vol. 1 (Conn P. M., ed.), pp. 164-181. Academic Press, San Diego.
30. Moorman J. M., Jackson A., Grahame-Smith D. G. and Leslie R. A. (1995) Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels. Neuroscience 68, 1089-1096.
31. 1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur. J. Pharmacol. 372, 127-134.
32. Paxinos G. and Watson C. (1986) in The Rat Brain in Stereotaxic Co-Ordinates. Academic Press, Sydney.
33. Pei Q., Lewis L., Sprakes M. E., Jones E. J., Grahame-Smith D. G. and Zetterstrom T. S. C. (2000) Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology 39, 463-470.
34. Romero L. and Artigas F. (1997) Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. J. Neurochem. 68, 2593-2603.
35. Sleight A. J., Marsden C. A., Martin K. F. and Palfreyman M. G. (1988) Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and 1-tryptophan. Br. J. Pharmacol. 93, 303-310.
36. 1B receptor and antidepressant effect of selective serotonin reuptake inhibitors. C. R. Seances Soc. Biol. Fil. 192, 1139-1147.
37. 1A receptor antagonists. Eur. J. Pharmacol. 357, 179-184.
38. Yamagata K., Suzuki K., Sugiura H., Kawashima N. and Okuyama S. (2000) Activation of an effector immediate-early gene arc by methamphetamine. Ann. N Y Acad. Sci. 914, 22-32.